BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18621717)

  • 1. Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.
    Shukla AK; Violin JD; Whalen EJ; Gesty-Palmer D; Shenoy SK; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9988-93. PubMed ID: 18621717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
    Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.
    Bonde MM; Hansen JT; Sanni SJ; Haunsø S; Gammeltoft S; Lyngsø C; Hansen JL
    PLoS One; 2010 Nov; 5(11):e14135. PubMed ID: 21152433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR).
    Xiao K; Sun J; Kim J; Rajagopal S; Zhai B; Villén J; Haas W; Kovacs JJ; Shukla AK; Hara MR; Hernandez M; Lachmann A; Zhao S; Lin Y; Cheng Y; Mizuno K; Ma'ayan A; Gygi SP; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15299-304. PubMed ID: 20686112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.
    Magnan R; Escrieut C; Gigoux V; De K; Clerc P; Niu F; Azema J; Masri B; Cordomi A; Baltas M; Tikhonova IG; Fourmy D
    J Am Chem Soc; 2013 Feb; 135(7):2560-73. PubMed ID: 23323542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Violin JD; Lefkowitz RJ
    Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.
    Reiter E; Ahn S; Shukla AK; Lefkowitz RJ
    Annu Rev Pharmacol Toxicol; 2012; 52():179-97. PubMed ID: 21942629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle.
    Nuber S; Zabel U; Lorenz K; Nuber A; Milligan G; Tobin AB; Lohse MJ; Hoffmann C
    Nature; 2016 Mar; 531(7596):661-4. PubMed ID: 27007855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery.
    Correll CC; McKittrick BA
    J Med Chem; 2014 Aug; 57(16):6887-96. PubMed ID: 24697360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conformational signature of β-arrestin2 predicts its trafficking and signalling functions.
    Lee MH; Appleton KM; Strungs EG; Kwon JY; Morinelli TA; Peterson YK; Laporte SA; Luttrell LM
    Nature; 2016 Mar; 531(7596):665-8. PubMed ID: 27007854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the BRET 7TM receptor/beta-arrestin assay in drug discovery and screening.
    Heding A
    Expert Rev Mol Diagn; 2004 May; 4(3):403-11. PubMed ID: 15137906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
    Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
    J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
    Wei H; Ahn S; Barnes WG; Lefkowitz RJ
    J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
    Xiao K; Sun J
    Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors.
    Gimenez LE; Kook S; Vishnivetskiy SA; Ahmed MR; Gurevich EV; Gurevich VV
    J Biol Chem; 2012 Mar; 287(12):9028-40. PubMed ID: 22275358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs.
    Oishi A; Dam J; Jockers R
    ACS Sens; 2020 Jan; 5(1):57-64. PubMed ID: 31849219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling.
    Shukla AK; Xiao K; Lefkowitz RJ
    Trends Biochem Sci; 2011 Sep; 36(9):457-69. PubMed ID: 21764321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Arrestin regulation of myosin light chain phosphorylation promotes AT1aR-mediated cell contraction and migration.
    Simard E; Kovacs JJ; Miller WE; Kim J; Grandbois M; Lefkowitz RJ
    PLoS One; 2013; 8(11):e80532. PubMed ID: 24255721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-arrestins and G protein-coupled receptor trafficking.
    Tian X; Kang DS; Benovic JL
    Handb Exp Pharmacol; 2014; 219():173-86. PubMed ID: 24292830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.